4Filing Date: Feb 13, 2026

Colgate Palmolive (CL)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001225208-26-001844
Total Value$8.60M
Trades7
Insiders1

Transaction Details

Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin·Direct
Exercise · Acquire
Common Stock
Shares+15.00K
Price$76.41
Total Value$1.15M
Shares Owned After25.41K
Transaction DateFeb 12, 2026
Footnotes ▸

Exercise of stock options awarded under the issuer's incentive compensation plan.

Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin·Direct
Sell · Dispose
Common Stock
Shares-15.00K
Price$97.81
Total Value$1.47M
Shares Owned After10.41K
Transaction DateFeb 12, 2026
Footnotes ▸

Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-15.00K
Price$0.00
Total Value$0
Shares Owned After19.94K
Transaction DateFeb 12, 2026
ExpiresSep 10, 2028
Footnotes ▸

Exercise of stock options awarded under the issuer's incentive compensation plan. | Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin·Direct
Exercise · Acquire
Common Stock
Shares+35.00K
Price$76.41
Total Value$2.67M
Shares Owned After45.41K
Transaction DateFeb 11, 2026
Footnotes ▸

Exercise of stock options awarded under the issuer's incentive compensation plan.

Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin·Direct
Sell · Dispose
Common Stock
Shares-35.00K
Price$94.61
Total Value$3.31M
Shares Owned After10.41K
Transaction DateFeb 11, 2026
Footnotes ▸

Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-35.00K
Price$0.00
Total Value$0
Shares Owned After34.94K
Transaction DateFeb 11, 2026
ExpiresSep 10, 2028
Footnotes ▸

Exercise of stock options awarded under the issuer's incentive compensation plan. | Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin·Indirect · By Issuer's 401(k) Plan Trustee
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After4.57K

Post-Transaction Holdings

Tsourapas Panagiotis · COO, Eur., APac, Afr Eur, Skin
SecuritySharesChange
Common Stock29.98K-
Stock Option (Right to Buy)19.94K-50.00K (-71.49%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: COLGATE PALMOLIVE CO (CL) CIK: 0000021665 --- Reporting Owner --- Name: Tsourapas Panagiotis CIK: 0001576945 Role: Officer (COO, Eur., APac, Afr Eur, Skin) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-11 | Code: M (Exercise of derivative) Shares: +35,000 | Price: $76.41 Total Value: $2,674,350.00 Shares Owned After: 45,415 | Ownership: D (Direct) Footnotes: [F1] Exercise of stock options awarded under the issuer's incentive compensation plan. [Transaction #2] Security: Common Stock Date: 2026-02-11 | Code: S (Open market sale) Shares: -35,000 | Price: $94.61 Total Value: $3,311,325.50 Shares Owned After: 10,415 | Ownership: D (Direct) Footnotes: [F2] Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. [F3] Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. [Transaction #3] Security: Common Stock Date: 2026-02-12 | Code: M (Exercise of derivative) Shares: +15,000 | Price: $76.41 Total Value: $1,146,150.00 Shares Owned After: 25,415 | Ownership: D (Direct) Footnotes: [F1] Exercise of stock options awarded under the issuer's incentive compensation plan. [Transaction #4] Security: Common Stock Date: 2026-02-12 | Code: S (Open market sale) Shares: -15,000 | Price: $97.81 Total Value: $1,467,111.00 Shares Owned After: 10,415 | Ownership: D (Direct) Footnotes: [F2] Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. [F4] Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-02-11 | Code: M (Exercise of derivative) Shares: -35,000 | Price: $0.00 Exercisable: N/A | Expires: 2028-09-10 Shares Owned After: 34,938 | Ownership: D (Direct) Footnotes: [F1] Exercise of stock options awarded under the issuer's incentive compensation plan. [F5] Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date. [Transaction #2] Security: Stock Option (Right to Buy) Date: 2026-02-12 | Code: M (Exercise of derivative) Shares: -15,000 | Price: $0.00 Exercisable: N/A | Expires: 2028-09-10 Shares Owned After: 19,938 | Ownership: D (Direct) Footnotes: [F1] Exercise of stock options awarded under the issuer's incentive compensation plan. [F5] Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) [Holding #2] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: Exercise of stock options awarded under the issuer's incentive compensation plan. F2: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date. --- Signature --- /s/ /s/ Kristine Hutchinson, Attorney-in-Fact (2026-02-13)

keid analysis is for reference only and does not constitute investment advice.